Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss objective risk assessment versus standard care for acute coronary syndromes (AGRIS—2:08); the relationship between hypoglycemia, cardiovascular outcomes, and empagliflozin treatment (EMPA-REG OUTCOME—3:56); and maximum-fixed energy versus low-escalating energy shocks for cardioversion of atrial fibrillation (CHESS—5:02).

Keywords: ESC Congress, ESC 19, Arrhythmias, Cardiac, Arrhythmia, Sinus, Atrial Fibrillation, Burns, Electric, Electric Countershock, Myocardium, Pain, Secondary Prevention, Shock, Acute Coronary Syndrome, Angina, Unstable, Angiotensin Receptor Antagonists, Aspirin, Cardiac Rehabilitation, Cardiology Interventions, Coronary Angiography, Heart Failure, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Medical Futility, Medication Adherence, Myocardial Infarction, Risk Factors, Secondary Prevention, Standard of Care, Diabetes Mellitus, Type 2, Glucose, Heart Failure, Glycated Hemoglobin A, Hyperglycemia, Hypoglycemic Agents, Insulin, Kidney Diseases, Metabolic Syndrome, Metformin, Myocardial Infarction, Primary Prevention, Stroke, Sulfonylurea Compounds

< Back to Listings